retatrutide clinical trial results 2025 Tirzepatide shows 47% greater weight loss vs. Wegovy Retatrutide produces up to 30.3%

Semaglutide 24 Mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2): A randomised, double-blind, double-dummy, placebo-controlled, phase 3 trial

Expert Care for Your Weight Loss Journey Tailored GLP-1 treatments under medical supervision

Most gastroenterologists advise against GLP-1 medications for patients with moderate to severe gastroparesis

doi: 10.1172/JCI15784 128 ToyotaHDugovicCKoehlMLaposkyADWeberCNgoKet al

Pharmaceutical companies price based on value and competition, not just manufacturing costs

For patients starting GLP-1 therapy For patients adjusting doses For patients tracking side effects or progress For patients who love data (or just a little structure) Keep going